While each laboratory reporting ABCG2 had their own noncanonical name, the common name for ABCG2 was breast cancer resistance protein (BCRP), alluding to its discovery from a drug-resistant breast cancer cell line (Doyle et al., 1998). This evidence concerns the gene ABCG2 and breast carcinoma.